The FDA has announced that the distribution of the Johnson & Johnson COVID-19 will be paused after six women in the U.S. had rare blood-clotting after receiving the vaccine. The women were ranging in ages from 18 to 48, and while six people may not seem like a lot precautions are being taken swiftly. There have been approximately 6.8 million shots given with the majority of people not having issues.
The pausing of the Johnson & Johnson vaccine does not affect the other two vaccines from Pfizer and Moderna. But if you did receive the Johnson & Johnson shot and are having to severe stomach pain, leg cramps, or severe headaches you should call your healthcare provider right away. If you do not know what shot you received, check your CDC vaccination card where it is noted what brand shot you received. If you have an appointment scheduled to receive the Johnson & Johnson COVID-19 vaccine, it is advised to call your provider for further directions.
Get Breaking News & Exclusive Contest in Your Inbox:
- Suspects Arrested & Charged in Connection to Takeoff’s Murder [Photos]
- Has A Suspect Been Has An Arrest Been Made In The Case Of Shanquella Robinson? In The Case Of Shanquella Robinson
- Twitter Drags Kyle Rittenhouse For Appearing To Compare Himself To Jesus Christ
- Keisha Knight Pulliam And Husband Brad James Expecting First Child Together
- Cardi B’s Farewell Collection With Reebok Is Serving Major Looks
- You’ve Got Nerve: Wendy Williams’ Ex Requests More Money From Guardian
- TI Stops By PV + TSU, Talks Tech And Business With Local Students
- LeBron James Calls Out Reporters For Not Asking Him About The Jerry Jones Photo
- Why Haven’t Houston Police Solved Takeoff’s Murder? Bother Pens Emotional Letter
- Tia Mowry Shares A Sweet Post On Teaching Her Daughter Self Love
FDA is Recommending Pausing the Use of Johnson and Johnson Vaccine in the U.S. was originally published on mycolumbusmagic.com